Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Mentholatum (China) Pharmaceuticals Co., Ltd.
EIR
•Mentholatum (China) Pharmaceuticals Co., Ltd.•June 21, 2019

Mentholatum (China) Pharmaceuticals Co., Ltd. – FDA EIR, Jun 21, 2019

Record Details

A comprehensive FDA inspection of Mentholatum (China) Pharmaceuticals Co., Ltd., conducted from June 17-21, 2019, focused on the manufacturing of Over-the-Counter (OTC) drug products. The inspection, carried out under established drug manufacturing guidelines (CPGM 7356.002), assessed the company's quality, materials, production, and laboratory control systems to ensure compliance with current Good Manufacturing Practices (cGMP).

The inspection resulted in two significant observations documented on a Form FDA-483. Firstly, the company's laboratory controls were found to lack scientifically robust test procedures necessary to ensure that raw materials and finished drug products consistently meet standards for identity, strength, quality, and purity. Secondly, there was a failure to thoroughly investigate unexplained discrepancies and instances where batches or their components did not conform to specifications, even if products had already been distributed.

While previous inspection findings regarding GMP training, test method accuracy, drug product storage, and stability programs were reviewed and addressed, the current observations highlight persistent issues in quality assurance. The company's General Manager committed to providing a written response to the agency within 15 business days. The inspection was classified as "Voluntary Action Indicated" (VAI), with a recommendation for re-inspection as part of the routine work plan to ensure sustained compliance.

Company
Mentholatum (China) Pharmaceuticals Co., Ltd.
Inspection date
June 21, 2019
Product type
drugs
Office
Division of Pharmaceutical Quality Operations IV
People
  • Gerard De Leon (Registered Nurse)
  • Uttaniti Limchumroon
View Company Profile

ID · 24c6ec30-dea0-4232-b694-2141df019878

Violation Codes3
21 CFR 211.160(b)21 CFR 211.19221 CFR 820.50

Full citation text and observation details available on the Dashboard.

Other documents for Mentholatum (China) Pharmaceuticals Co., Ltd.
  • 483 - 2019-06-21June 21, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Mentholatum (China) Pharmaceuticals Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.